Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$11.00
-2.3%
$11.74
$9.46
▼
$23.29
$937.32M1.141.52 million shs492,486 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
-4.09%-10.43%+17.80%-32.80%-13.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$11.00
-2.3%
$11.74
$9.46
▼
$23.29
$937.32M1.141.52 million shs492,486 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
-4.09%-10.43%+17.80%-32.80%-13.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
2.60
Moderate Buy$31.33184.98% Upside

Current Analyst Ratings Breakdown

Latest MLTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/13/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
DowngradeSell (D-) ➝ Sell (E+)
11/12/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
Set Price TargetOutperform$34.00
11/6/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
Initiated CoverageBuy$57.00
10/5/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
Reiterated RatingBuy$50.00
9/16/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
Reiterated RatingOverweight
8/21/2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
N/AN/AN/AN/A$4.48 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
-$227.32M-$3.67N/AN/AN/AN/A-79.95%-56.40%N/A

Latest MLTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
-$0.8326-$0.93-$0.0974-$0.93N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
0.26
9.13
9.13

Institutional Ownership

CompanyInstitutional Ownership
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
93.85%

Insider Ownership

CompanyInsider Ownership
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
10.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
13085.11 million76.26 millionOptionable

Recent News About These Companies

What is HC Wainwright's Estimate for MLTX FY2026 Earnings?
How Moonlake Immunotherapeutics (MLTX) Affects Rotational Strategy Timing
MoonLake Immunotherapeutics (MLTX) Gets a Buy from Guggenheim

New MarketBeat Followers Over Time

Media Sentiment Over Time

MoonLake Immunotherapeutics stock logo

MoonLake Immunotherapeutics NASDAQ:MLTX

$10.99 -0.26 (-2.33%)
As of 01:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.